top of page
Richard M Fleming, PhD, MD, JD
Fleming Method
Using the Knowledge Acquired over Two Decades
Differentiating Tissue Based Upon Fleming Method Measurements of Metabolic & Regional Blood Flow Differences (RBFDs), Fleming Method (FMTVDM)
Can Also be Used to Measure Changes in Tissue looking for Infection and Inflammation/Blood Clotting
(InflammoThrombotic Response - ITR)
to the Infection.
Like Heart Disease and Cancer, FMTVDM, can be used both for diagnosis but also measurement of success or failure of treatment(s).
Using Fleming Method 1800 People Were Studied After Becoming Infected with SARS-CoV-2, Measuring Both the Severity of Their COVID-19 Disease and Their Treatment Responses.
Patients Admitted to Hospital with COVID-19 Underwent Fleming Method in Addition to Other Tests to Measure Tissue COVID-19 Severity and Tissue Response to Treatments.
The Following is the result of Fleming Method Evaluation of COVID-19 Severity and Treatment Response in One of Those Patients.
Fleming Method Measurements Showed a Failure of the Patient to Initially Respond to Hydroxychloroquine & Azithromycin. She Responded when Methylprednisolone was Added to her Treatment Regimen.
On 8 September 2022
The first National/International Medical Conference,
The American Society of Nuclear Cardiology,
Released the Results of Published Research
Looking at Successful Treatments for
SARS-CoV-2 and COVID-19
Using FMTVDM/Fleming Method
Figures Explaining Sites of Drug Effect & Mechanism of Action.
bottom of page